
Ganapathy Krishnan
Examiner (ID: 6885, Phone: (571)272-0654 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1693, 1673 |
| Total Applications | 1710 |
| Issued Applications | 810 |
| Pending Applications | 207 |
| Abandoned Applications | 716 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15321021
[patent_doc_number] => 20200000840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => USE OF CYCLODEXTRINS TO REDUCE ENDOCYTOSIS IN MALIGNANT AND NEURODEGENERATIVE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/086946
[patent_app_country] => US
[patent_app_date] => 2017-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27443
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16086946
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/086946 | USE OF CYCLODEXTRINS TO REDUCE ENDOCYTOSIS IN MALIGNANT AND NEURODEGENERATIVE DISORDERS | Mar 19, 2017 | Abandoned |
Array
(
[id] => 17859786
[patent_doc_number] => 11440931
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-13
[patent_title] => Crocins compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/097166
[patent_app_country] => US
[patent_app_date] => 2017-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5279
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097166
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097166 | Crocins compounds and uses thereof | Mar 15, 2017 | Issued |
Array
(
[id] => 14132315
[patent_doc_number] => 20190100547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => METHOD FOR PREPARING 2'-O-FUCOSYLLACTOSE
[patent_app_type] => utility
[patent_app_number] => 16/082581
[patent_app_country] => US
[patent_app_date] => 2017-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16082581
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/082581 | METHOD FOR PREPARING 2'-O-FUCOSYLLACTOSE | Mar 7, 2017 | Abandoned |
Array
(
[id] => 14519075
[patent_doc_number] => 10336784
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => Methods for modular synthesis of N-glycans and arrays thereof
[patent_app_type] => utility
[patent_app_number] => 15/453836
[patent_app_country] => US
[patent_app_date] => 2017-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 237
[patent_figures_cnt] => 248
[patent_no_of_words] => 67346
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 240
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15453836
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/453836 | Methods for modular synthesis of N-glycans and arrays thereof | Mar 7, 2017 | Issued |
Array
(
[id] => 11864731
[patent_doc_number] => 20170232017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/443698
[patent_app_country] => US
[patent_app_date] => 2017-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14531
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15443698
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/443698 | TREATMENT OF CANCER | Feb 26, 2017 | Abandoned |
Array
(
[id] => 16913879
[patent_doc_number] => 20210186971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => BRAIN HEALTH FOOD OR BRAIN HEALTH BEVERAGE, AND METHOD FOR ADMINISTERING SAME
[patent_app_type] => utility
[patent_app_number] => 16/080983
[patent_app_country] => US
[patent_app_date] => 2017-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5670
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16080983
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/080983 | BRAIN HEALTH FOOD OR BRAIN HEALTH BEVERAGE, AND METHOD FOR ADMINISTERING SAME | Feb 26, 2017 | Abandoned |
Array
(
[id] => 12246296
[patent_doc_number] => 09919060
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-20
[patent_title] => 'Treatment or prophylaxis of proliferative conditions'
[patent_app_type] => utility
[patent_app_number] => 15/425758
[patent_app_country] => US
[patent_app_date] => 2017-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 39356
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15425758
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/425758 | Treatment or prophylaxis of proliferative conditions | Feb 5, 2017 | Issued |
Array
(
[id] => 11625786
[patent_doc_number] => 20170135975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'METHOD FOR TREATING NEUROTRAUMA'
[patent_app_type] => utility
[patent_app_number] => 15/417943
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7863
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15417943
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/417943 | Method for treating neurotrauma | Jan 26, 2017 | Issued |
Array
(
[id] => 16635267
[patent_doc_number] => 10913762
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-09
[patent_title] => Process for the preparation of D-glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl] oxy]phenyl] methyl] phenyl]-, (1S) and its crystalline forms thereof
[patent_app_type] => utility
[patent_app_number] => 16/073714
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 10224
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073714
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073714 | Process for the preparation of D-glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl] oxy]phenyl] methyl] phenyl]-, (1S) and its crystalline forms thereof | Jan 26, 2017 | Issued |
Array
(
[id] => 16946649
[patent_doc_number] => 20210205340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => COMPOSITIONS COMPRISING SIALYLATED OLIGOSACCHARIDES FOR USE IN INFANTS OR YOUNG CHILDREN TO PREVENT LATER IN LIFE OBESITY OR RELATED COMORBIDITIES AND PROMOTE A HEALTHY GROWTH
[patent_app_type] => utility
[patent_app_number] => 16/071323
[patent_app_country] => US
[patent_app_date] => 2017-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11152
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071323
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071323 | COMPOSITIONS COMPRISING SIALYLATED OLIGOSACCHARIDES FOR USE IN INFANTS OR YOUNG CHILDREN TO PREVENT LATER IN LIFE OBESITY OR RELATED COMORBIDITIES AND PROMOTE A HEALTHY GROWTH | Jan 25, 2017 | Abandoned |
Array
(
[id] => 12603312
[patent_doc_number] => 20180092934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-05
[patent_title] => COMPOSITION FOR DNA PROTECTION
[patent_app_type] => utility
[patent_app_number] => 15/394117
[patent_app_country] => US
[patent_app_date] => 2016-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15394117
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/394117 | COMPOSITION FOR DNA PROTECTION | Dec 28, 2016 | Abandoned |
Array
(
[id] => 12857596
[patent_doc_number] => 20180177706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => COMPOSITIONS CONTAINING HYALURONIC ACID AND SYNERGISTIC ANTI-HYALURONIDASE ACTIVES
[patent_app_type] => utility
[patent_app_number] => 15/390220
[patent_app_country] => US
[patent_app_date] => 2016-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5744
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15390220
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/390220 | COMPOSITIONS CONTAINING HYALURONIC ACID AND SYNERGISTIC ANTI-HYALURONIDASE ACTIVES | Dec 22, 2016 | Abandoned |
Array
(
[id] => 13727985
[patent_doc_number] => 20180368460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => MIXTURE OF HMOs
[patent_app_type] => utility
[patent_app_number] => 16/062598
[patent_app_country] => US
[patent_app_date] => 2016-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8170
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16062598
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/062598 | Mixture of HMOs | Dec 14, 2016 | Issued |
Array
(
[id] => 16336746
[patent_doc_number] => 10787693
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-29
[patent_title] => Single-chain beta-glucan composition, method for producing same, and liquid composition
[patent_app_type] => utility
[patent_app_number] => 16/062091
[patent_app_country] => US
[patent_app_date] => 2016-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5638
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16062091
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/062091 | Single-chain beta-glucan composition, method for producing same, and liquid composition | Dec 13, 2016 | Issued |
Array
(
[id] => 12253179
[patent_doc_number] => 09925310
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-27
[patent_title] => 'Biocompatible and bioabsorbable derivatized chitosan compositions'
[patent_app_type] => utility
[patent_app_number] => 15/371010
[patent_app_country] => US
[patent_app_date] => 2016-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 23
[patent_no_of_words] => 14146
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15371010
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/371010 | Biocompatible and bioabsorbable derivatized chitosan compositions | Dec 5, 2016 | Issued |
Array
(
[id] => 13507691
[patent_doc_number] => 20180305388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => CRYSTAL OF 6'-SIALYLLACTOSE SODIUM SALT, AND PROCESS FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 15/769025
[patent_app_country] => US
[patent_app_date] => 2016-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15769025
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/769025 | Crystal of 6'-sialyllactose sodium salt, and process for producing same | Nov 17, 2016 | Issued |
Array
(
[id] => 11602431
[patent_doc_number] => 20170119731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'CDC7 KINASE INHIBITORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/349905
[patent_app_country] => US
[patent_app_date] => 2016-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 29286
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15349905
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/349905 | CDC7 kinase inhibitors and uses thereof | Nov 10, 2016 | Issued |
Array
(
[id] => 16476438
[patent_doc_number] => 10851367
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-01
[patent_title] => Tissue-specific genome engineering using CRISPR-Cas9
[patent_app_type] => utility
[patent_app_number] => 15/347339
[patent_app_country] => US
[patent_app_date] => 2016-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 6
[patent_no_of_words] => 76051
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 665
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15347339
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/347339 | Tissue-specific genome engineering using CRISPR-Cas9 | Nov 8, 2016 | Issued |
Array
(
[id] => 13549053
[patent_doc_number] => 20180326074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => METHODS FOR SYNTHESIZING PEPTIDE-TAGGED PEGYLATED CHITOSAN
[patent_app_type] => utility
[patent_app_number] => 15/775552
[patent_app_country] => US
[patent_app_date] => 2016-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15775552
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/775552 | METHODS FOR SYNTHESIZING PEPTIDE-TAGGED PEGYLATED CHITOSAN | Nov 7, 2016 | Abandoned |
Array
(
[id] => 11604128
[patent_doc_number] => 20170121428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'SULFATED POLYSACCHARIDE COMPOUND AND THE PREPARATION AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/336607
[patent_app_country] => US
[patent_app_date] => 2016-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 11064
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15336607
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/336607 | SULFATED POLYSACCHARIDE COMPOUND AND THE PREPARATION AND USE THEREOF | Oct 26, 2016 | Abandoned |